علاج ساركوما إيوينغ في المظهر الجلدي أو تحت الجلدي

References

DOI: 10.1016/j.annonc.2021.08.1995

• There is retrospective evidence suggesting that cutaneous and subcutaneous ES have a better prognosis compared with other localised soft tissue ES.
• Given their favourable prognosis, the number of cycles in cutaneous and subcutaneous ES is to be discussed case by case, at a multidisciplinary level and with the patient [V, C].
• Treatment of patients with extraskeletal ES follows the same principles as for bone ES, thus incorporating ChT in all cases as well as RT in most cases [IV, B].
• Complete surgical excision, where feasible, is regarded as the best modality of local control, given the higher risk of LR when RT is used as the sole treatment [IV, A].
• Recent studies suggest that 100% response is most optimal to define a good tumour response in ES.
• Change in the size of the soft tissue mass is easily evaluated on MRI, a good predictor of tumour response.